Form D · Other Health Care
Transplant Genomics Inc.
Mansfield, MA · CIK 0001604710
Offering snapshot reported Sep 6, 2018 · SEC filing
- Reported sold
- $7.98M Offering amount: $7.98M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 24, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2018 | Initial | $7,977,713 | No comparison | 31 | SEC filing |
| Apr 5, 2017 | Initial | $3,169,532 | No comparison | 27 | SEC filing |
| Feb 3, 2017 | Amendment | $1,705,104 | $284,183vs Jan 6, 2017 | 22 | SEC filing |
| Jan 6, 2017 | Initial | $1,420,921 | No comparison | 22 | SEC filing |
| May 9, 2016 | Initial | $530,000 | No comparison | 8 | SEC filing |
| Oct 16, 2015 | Initial | $1,200,000 | No comparison | 12 | SEC filing |
| May 28, 2015 | Amendment | $3,200,008 | $1,530,086vs Dec 5, 2014 | 47 | SEC filing |
| Dec 8, 2014 | Amendment | $1,694,920 | $24,998vs Dec 5, 2014 | 41 | SEC filing |
| Dec 5, 2014 | Initial | $1,669,922 | No comparison | 41 | SEC filing |
| Apr 4, 2014 | Initial | $2,815,000 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $200K
- Finders' fees
- $0
- Form D file number
- 021-320736
Total amount sold includes $3,482,961 of converted indebtedness and accrued interest.
Source: Form D, filed Sep 6, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Abecassis | Director |
| Roy First | Executive |
| Kyle Hart | Executive |
| Brett Jensen | Executive |
| David Kravitz | Director |
| Darren Lee | Executive |
| Peter Lewis | Executive |
| Chris O'connor | Director |
| Dierdre Pierry | Executive |
| Stanley Rose | Director, Executive |
| Daniel Salomon | Director |
| Daniel Solomon | Director |
| Jay Venkatesan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
905 S. Main Street Suite 202
Mansfield, MA, 02048
Mansfield, MA, 02048